Reumuth Mary Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
12
Insider Sells Sum
$150,821.69

Insider Activity of Reumuth Mary

Biography of Reumuth Mary

No biography is available at this moment.

2025-06-24SaleKala Pharmaceuticals, Inc.
KALA
CHIEF FINANCIAL OFFICER
3,631
0.0564%
$4.01$14,560-84.18%
2025-06-03SaleKala Pharmaceuticals, Inc.
KALA
CHIEF FINANCIAL OFFICER
2,850
0.0404%
$3.74$10,659-83.01%
2025-01-06SaleKala Pharmaceuticals, Inc.
KALA
CHIEF FINANCIAL OFFICER
1,706
0.0377%
$7.63$13,017-38.08%
2024-06-26SaleKala Pharmaceuticals, Inc.
KALA
CHIEF FINANCIAL OFFICER
4,163
0.1526%
$4.75$19,774+34.78%
2024-05-31SaleKala Pharmaceuticals, Inc.
KALA
CHIEF FINANCIAL OFFICER
1,786
0.0575%
$6.09$10,877-6.55%
2024-01-04SaleKala Pharmaceuticals, Inc.
KALA
CHIEF FINANCIAL OFFICER
1,227
0.0438%
$6.74$8,270-3.29%
2023-01-04SaleKala Pharmaceuticals, Inc.
KALA
CHIEF FINANCIAL OFFICER
60
0.002%
$28.54$1,712-66.31%
2022-10-26SaleKala Pharmaceuticals, Inc.
KALA
CHIEF FINANCIAL OFFICER
194
0.0125%
$6.51$1,263+128.75%
2022-06-27SaleKala Pharmaceuticals, Inc.
KALA
CHIEF FINANCIAL OFFICER
2,613
0.0036%
$0.37$967-16.78%
2022-01-04SaleKala Pharmaceuticals, Inc.
KALA
CHIEF FINANCIAL OFFICER
5,700
0.0079%
$1.30$7,410-72.66%
2021-10-26SaleKala Pharmaceuticals, Inc.
KALA
CHIEF FINANCIAL OFFICER
18,898
0.0291%
$1.80$34,016-61.96%
2021-06-28SaleKala Pharmaceuticals, Inc.
KALA
CHIEF FINANCIAL OFFICER
4,904
0.0079%
$5.77$28,296-72.03%
Total: 12
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.